Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 702, pseudogene** (RNU6-702P) is a human pseudogene related to the U6 small nuclear RNA (snRNA) family. U6 snRNA plays a central role in *pre-mRNA splicing* as an essential component of the spliceosome; however, RNU6-702P is a non-functional *pseudogene* copy of this RNA family and does not encode an active molecule involved in splicing[1][3][5]. Pseudogenes like RNU6-702P generally contain sequence similarities to their functional counterparts but have accumulated disabling mutations that prevent them from participating in canonical biological processes[2][4]. While some pseudogenes can have regulatory effects or serve as raw material for evolutionary innovation, most—including RNU6-702P—are considered "genomic fossils" without confirmed function or therapeutic relevance[2][4][5]. There is no evidence that RNU6-702P interacts with drugs, serves as a biomarker, or is used therapeutically. Key context: - The designation "pseudogene" indicates RNU6-702P is generally *not a protein/RNA drug target*, nor does it function in cell signaling, metabolism, or other classical "targetable" biology[2][4]. - Many U6-related pseudogenes are dispersed throughout vertebrate genomes as a result of retroposition or gene duplication[1][5]. - Functional U6 snRNA is essential for life; pseudogenes such as RNU6-702P lack this function[1][5]. - Some pseudogenes, in rare cases, may acquire new (regulatory) functions; there is no evidence this applies to RNU6-702P[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 702, pseudogene (RNU6-702P).